Skip to content
HUB Organoids
services
services overview
drug screening
model and assay development
clinical trials in a dish
technology
company
about us
careers
events
latest news
resources
license program
contact
Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
eLife | Nov 2016
X
Have any questions?